P3 Health Partners Inc expected to post a loss of 11 cents a share - Earnings Preview

P3 Health Partners

25/03/2025 20:36

P3 Health Partners Inc PIII.OQ PIII.O is expected to show a rise in quarterly revenue when it reports  results on March 27 for the period ending December 31 2024

The Chicago Illinois-based  company is expected to report a 9.0% increase in revenue to $378.056 million from $346.86 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

​LSEG's mean analyst estimate for P3 Health Partners Inc is for a loss of 11 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for P3 Health Partners Inc is $1.00​, above​ its last closing price of $0.19. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.04
-0.04
-0.29
Missed
-673.3
Jun. 30 2024
-0.07
-0.05
-0.09
Missed
-80
Mar. 31 2024
-0.11
-0.11
-0.16
Missed
-50​
Dec. 31 2023
-0.19
-0.11
-0.22
Missed
-100
​​Sep. 30 2023
-0.29
-0.22
-0.12
Beat
45.5
Jun. 30 2023
-0.14
-0.13
-0.09
Beat
30.8​
Mar. 31 2023
-0.63
-0.67
-0.22
Beat
67.4
Dec. 31 2022
-0.91
-2.26
Missed
-148.4

This summary was machine generated March 25 at 20:36 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)